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Abstract
Background: The EuroQol Group has extended the severity levels of the EQ-5D from three to five (EQ-5D-5L).
There are valuation studies worldwide planned in order to convert the EQ-5D-5L health states into a single
preference-based summary score based on country-specific value sets of social health status preference valuations.
The EuroQol Group developed an internationally standardised EQ-5D-5L valuation protocol. Based on the
experiences of the first wave of valuation studies applying the protocol, a number of modifications to the
implementation of composite time trade-off (cTTO) were proposed and tested in an exploratory study in Germany.
Methods: The aim of the study is to test the improved EQ-5D-5L valuation protocol 1.1 and the implementation of
three modifications: (1) introduction of ranking task, (2) separating time trade-off (TTO) tasks for health states “Better
Than Dead“(BTD)/“Worse Than Dead” (WTD), (3) allow for removal of problematic valuations from the cTTO data
(the feedback module). Data were collected in computer assisted personal interviews with 200 members of the
German general public.
Results: In comparison to the first wave of valuation studies a higher data quality can be observed in both study
arms: increasing number of WTD valuations, reduced inconsistencies for health state 55555 as well as higher values
for mild health states. Comparing both study arms, mean observed cTTO value for severity 6 is higher in the test
arm. The proportion of inconsistent cTTO responses is lower in the test arm than in the control arm and is further
reduced by the feedback module. The ranking task prolongs the interview without the desired effect.
Conclusions: Both study arms yielded higher data quality in comparison to the first wave of EQ-5D-5L valuation
studies. The valuation protocol combined with an intensive interviewer training and close data monitoring showed
a high feasibility and acceptability to the respondents of the general population as well as the interviewers in
Germany. Based on the results of this study and other countries, the separation of TTO tasks for health states BTD/
WTD and the feedback module will be implemented in the valuation study for the EQ-5D-5L for Germany.
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Background
The EQ-5D 3-level version (EQ-5D-3L) is a multidimen-
sional instrument for the measurement of health-related
quality of life (HrQoL) developed and provided by the
EuroQol Group. The questionnaire allows collecting de-
scriptive data on individuals’ HrQoL profile on five di-
mensions (mobility, self-care, usual activities, pain/
discomfort, anxiety/depression). Furthermore, it includes
a self-rating of health status on a visual analogue scale
(EQ VAS) ranging from 0 to 100 [1]. By now the EQ-
5D-3L belongs to the most commonly applied generic
HrQoL instruments in Germany [2]. There is an increas-
ing demand for the EQ-5D-3L and the corresponding
value set in Germany (not least because Germany is a
country with a great market volume for pharmaceuti-
cals). Moreover, the German version of the EQ-5D-3L
and its value set is applied in studies in other German-
speaking countries like Austria and Switzerland.
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To increase the sensitivity and to reduce ceiling effects
of the existing EQ-5D-3L, the EuroQol Group raised the
number of answering levels from three to five (no, slight,
moderate, severe and extreme problems/unable to) in a
new version of the questionnaire, the so-called EQ-5D-
5L (5-level version), which allows to describe 3,125 (=55)
health states [3, 4].
In contrast to the EQ-5D-3L, there is only a crosswalk
value set available to convert each EQ-5D-5L health
state into a single preference-based summary score as
there is currently no set of social health status prefer-
ence valuations available for the German context [5, 6].
The current value set for the German version of the EQ-
5D has been generated more than ten years ago [7] and
there is also a demand for a new valuation, because the
questionnaire has been changed from a 3-level to a 5-
level version. In order to use the extended instrument in
cost-utility analysis it is essential to generate such a
value set for the German context. Combining these ar-
guments, there is an urgent need for an updated value
set for the 5-level EQ-5D version in Germany.
The EuroQol Group has developed an internationally
standardised protocol with an accompanying computer-
based valuation software (the EuroQol – Valuation
Technology version 1.0, EQ-VT 1.0) for the valuation of
the EQ-5D-5L [3, 8]. In the first wave of EQ-5D-5L valua-
tion studies applying the protocol, major data issues
were observed, particularly with respect to the compo-
site time trade-off (cTTO) (see detailed description of the
data issues elsewhere [9]). Firstly, quality issues concern-
ing the cTTO distribution suggest that the discrimina-
tive capability of the valuation task in the EQ-VT is too
low to adequately deal with the increased severity of
the EQ-5D-5L descriptive system: few observations
between −0.5 and 0, spikes (i.e. clustering of valua-
tions at −1, −0.5, 0, 0.5, 1) and lower than expected values
for mild health states (i.e. a big gap to 1). Extending the
descriptive system from three to five levels aimed at in-
creasing the discriminative capacity and the sensitivity to
change in comparison to the EQ-5D-3L as well as reduc-
ing the ceiling effects, especially for small changes in
health and for patients with mild health problems [4].
Therefore, the valuation task of the extended instrument
must also be sufficiently responsive to these small
changes, indicating that the respondents can distinguish
between these health states [9]. Moreover, due to the la-
belling of level 2 as “slight problems” in the EQ-5D-5L a
small gap from the perfect health to the next best health
state is expected [10]. Secondly, there was a high number
of inconsistencies overall and with regard to the worst
possible health state 55555 with the highest level of health
problems on each dimension (i.e. valuing less severe
health states lower than the value for 55555). This quality
issue might undermine the face validity of the results as
well as impair the data modelling. Thirdly, another quality
issue was related to the low number of health state valua-
tions “Worse Than Dead” (WTD) which might be an arte-
fact of the valuation methodology in the EQ-VT [9–11].
The resulting narrow value range due to low values for
mild health states and high values for severe health states
was not expected. The selective scale use in the EQ-VT
and the possible causes need to be further investigated.
Shah et al. assumed that those data quality issues
could relate to the way in which the cTTO tasks
were implemented in the EQ-VT 1.0 [9]. Moreover,
post-hoc analyses of the data collected in the EQ-5D-
5L valuation studies in Spain and in the Netherlands
indicated the presence of interviewer effects with re-
spect to both compliance to the EQ-5D-5L valuation
protocol and the cTTO values elicited [11–14].
Based on the experiences of the first five EQ-5D-5L
valuation studies, three modifications were immediately
added to the software and led to the EQ-VT version 1.1:
(1) the use of routine quality control (QC) checks, (2)
the introduction of three practise cTTO tasks (a mild
health state, a severe health state and a health state
which is hard to imagine), and (3) the inclusion of a
prompt each time the respondent completes a cTTO
task. Moreover, a number of other solutions were
worked out to address the described quality issues with
the EQ-VT 1.0 and to further develop the valuation
methodology for the EQ-5D-5L. Those solutions were
tested in a multi-country research programme [9].
Besides explorative studies in Spain, the Netherlands,
the UK and other countries, an experimental study was
undertaken in Germany as part of the EQ-VT method-
ology research programme. The objective of this study
was to test the improved EQ-5D-5L valuation protocol
(EQ-VT version 1.1) and the effect of adding three further
modifications to the current EQ-VT version 1.1 to improve
the software for further EQ-5D-5L valuation studies.
Methods
This study used the latest development in valuation
methodology in accordance with the EuroQol Group’s
protocol and guidelines for the implementation of the
protocol for the EQ-5D-5L valuation studies [8]. A com-
bination of two valuation elicitation techniques, includ-
ing a time trade-off (TTO) approach and a discrete
choice experiment (DCE), were applied in this study.
Both are choice-based techniques where the respondent
has to choose between different alternatives. In case of
the TTO, individuals are asked to indicate the amount
of remaining life years in full health, after a series of
choice-based iteration steps, at which the respondent is
indifferent between a longer period of impaired health
(i.e. an EQ-5D-5L health state) and a shorter life span in
a state of full health [15]. Thereby, a cTTO approach is
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used which involves beginning with the ‘conventional’
TTO for all EQ-5D-5L health states, and shifting to a
‘lead time’-TTO (LT-TTO) where the participants’ re-
sponses indicate that they consider the health state to be
worse than being dead (see Fig. 1) [3, 12, 16, 17]. Apply-
ing the DCE, respondents have to make a discrete choice
between two alternatives (e.g. two EQ-5D-5L health
states) according to their preferences [18, 19]. The TTO
method belongs to the most widely used and accepted
preference elicitation techniques. The DCE has attracted
a lot of attention in the area of health evaluation, as its
usage offers several advantages (e.g. the ease of compre-
hension and administration, and the greater reliability
due to a reduced measurement error) [18, 20].
The study was conducted according to the standardised
protocol (e.g. design, selection of health states and instruc-
tions for the interviewers) and used a standardised
software platform for the valuation studies, the EQ-VT
version 1.1. In this study the implementation of the
following three modifications to the current EQ-VT
version 1.1 was analysed:
1. Ranking task: introduction of a ranking task prior to
the cTTO valuation,
2. “Better Than Dead” (BTD)/WTD split: separating
the TTO tasks for health states BTD and WTD,
3. Feedback module: presenting respondents with the
rank ordering implied by their cTTO responses and
allowing for removal of problematic valuations from
the data.
Table 1 summarises the three modifications and the
hypotheses being tested in this study. Those three modi-
fications were also tested in other experimental studies of
the EuroQol Group: the ranking task (Spain [21], Japan),
the BTD/WTD split (Hong Kong, the Netherlands [22])
and the feedback module (e.g. Spain [21], the Netherlands
[22]) [9].
Methods of eliciting preferences and valuation interview
The EQ-5D-5L descriptive system consists of five di-
mensions of health with each dimension distinguishing
five levels of severity ranging from no problems (1) to
extreme problems/unable to (5), which allows to de-
scribe 3,125 health states. In this study a sub-set of the
3,125 possible EQ-5D-5L health states was valued. The
selection of health states was based on the experimental
design which was developed as part of the EQ-5D-5L
valuation protocol [8]. For the cTTO tasks an efficient
experimental design was generated based on a set of 80
EQ-5D-5L health states, divided into ten blocks of eight
health states. The worst possible health state 55555 and
one of the five very mild EQ-5D-5L health states were
then added to each block, resulting in a total of ten
health states per block, balanced in terms of severity.
The efficient design developed for the DCE task consists
of 196 pairs of EQ-5D-5L health states divided into 28
blocks of seven pairs. None of the pairs included an EQ-
5D-5L health state that logically dominates the other.
Each respondent was randomly assigned to one of the
ten blocks of cTTO tasks and to one of the 28 blocks of
DCE tasks. Health states within the blocks were ran-
domly presented to the respondents. The control arm
followed the existing protocol for the EQ-5D-5L valua-
tion studies (EQ-VT version 1.1). Each interview in the
control arm consisted of the following six parts:
1. Welcome and purpose of the study,
2. Self-reported health using the EQ-5D-5L and
background questions regarding age, gender and
experience of serious illness,
3. Valuation tasks applying the cTTO (wheelchair
example, three practise cTTO states, ten cTTO tasks,
three debriefing questions regarding cTTO tasks),
4. Valuation tasks applying the DCE (seven DCE tasks,
three debriefing questions regarding the DCE tasks),














Impaired health, i.e. EQ-5D-5L health state
Fig. 1 The composite time trade-off
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6. Further background questions specific to the German
valuation study (e.g. education, employment status).
Modification 1: the ranking task
In the experimental test arm, the ranking task was intro-
duced before the cTTO task. The ten EQ-5D-5L health
states to be valued in the later cTTO task and the state
“death” were ranked by the respondents using physical
cards as a warm-up exercise. The rank ordering of the
respondents was entered into the EQ-VT by the inter-
viewer and determined the order in which the health
states will be presented in the cTTO tasks (the ranking
and sorting approach): (1) top health state, (2) bottom
health state, (3) health state ranked midway between top
and bottom health states, (4) health state ranked midway
between top and middle health states, (5) health state
ranked midway between middle and bottom health
states and (6) the remaining health states one after an-
other [21]. Moreover, the ranked health states remained
visible on the table and the interviewer always referred
to the card representing the health state in the EQ-VT
during the cTTO tasks.
Modification 2: the BTD/WTD split
Before the respondents answer the practise states and
the ten cTTO tasks, the interviewer uses the example
health state “being in a wheelchair” to explain the cTTO
tasks by illustrating all elements and the iterative se-
quence of the task. The wheelchair example and the
practise states serve as warm-up tasks that are usually
conducted to prepare the respondent for the formal
valuation tasks using the cTTO [12]. In the control arm,
the cTTO was applied in the following way: After the re-
spondents were introduced to the cTTO task for the
health states BTD (‘conventional’ TTO) and the health
states WTD (LT-TTO) using the wheelchair example
and practised the cTTO task for three practise health
states, the respondents valued ten health states begin-
ning with the conventional TTO. The second iteration
step in all cTTO tasks involved choosing between
spending 0 years in full health in Life A and spending
ten years in the EQ-5D-5L health state under valuation,
followed by death (Life B). In other words, the respon-
dents were asked whether they consider living in the
health state for 10 years to be BTD or WTD (the sorting
question). Using an iterative procedure, the respondents’
value of that health state was then identified by finding
the number of years in full health (Life A) they consid-
ered equivalent to living for ten years in Life B (i.e. the
cTTO values for the health states BTD range between 0
and 1). However, every time a respondent indicated to
prefer immediate death over 10 years in the EQ-5D-5L
health state, the EQ-VT changed to the WTD format
(i.e. the LT-TTO). The LT-TTO approach applied in this
valuation study involved a twenty year time frame: ten
years of lead time followed by ten years in the EQ-5D-
5L health state, followed by death (see Fig. 1). The
respondents’ value of that health state was then investi-
gated by finding the point of indifference (i.e. the cTTO
values for health states WTD range between −1 and 0),
again using iterative steps. The iteration scheme of the
EQ-VT protocol is reported elsewhere [12].
In the test arm, the cTTO tasks for the health states
BTD and the health states WTD were separated in the
following way (the BTD/WTD split): After the respon-
dents were solely introduced to the cTTO task for the
health states BTD (‘conventional’ TTO) using the wheel-
chair example and practised the cTTO task for three
practise states, the respondents valued ten health states
beginning with the conventional TTO until the indiffer-
ence point was identified. However, every time a re-
spondent indicated to prefer immediate death over ten
years in the EQ-5D-5L health state (in the second itera-
tion step), that health state was temporarily parked.
The interview continued with the BTD format (i.e. con-
ventional TTO) for the remaining health states. After
completing all BTD tasks, the WTD task (i.e. LT-TTO)
was explained using the wheelchair example and after-
wards all temporarily parked health states considered
WTD were evaluated applying LT-TTO, again using itera-
tive steps. However, the respondents still had the pos-
sibility to reconsider their initial classification of a health
state being WTD and they were still able to switch to
the BTD format.
In both study arms, the values derived by the cTTO
range between 1 at maximum and −1 at minimum (see
Fig. 1). The maximum cTTO value of 1 means that the re-
spondent values the EQ-5D-5L health state to be as good
as being in full health (i.e. no trading of life years). A value
of 0 indicates that the respondent considers the EQ-5D-
5L health state to be neither BTD nor WTD. All cTTO
values below 0 imply that the respondent values the health
state to be WTD. Thereby, the minimum value is
restricted to −1 which means that the respondent can
Table 1 Overview of modifications and hypotheses tested in
this study
Modification Hypotheses tested
Ranking task Introducing the ranking task prior to the cTTO valuation
will reduce the inconsistencies and improves the overall
data quality (i.e. more WTD responses).
BTD/WTD split Separating the BTD and WTD cTTO tasks will reduce
the inconsistencies of the valuations and improve the
overall data quality (i.e. more WTD responses, higher
values for mild heath state and fewer spikes).
Feedback
module
Presenting respondents with the rank ordering implied
by their cTTO valuations will reduce the inconsistencies
as they will identify and flag problematic valuations for
removal from the data.
Ludwig et al. Health and Quality of Life Outcomes  (2017) 15:39 Page 4 of 13
trade-off 10 years of full health at maximum (i.e. trading
the whole lead time).
Modification 3: the feedback module
After completing the ten cTTO tasks, each respondent
of the experimental test arm was presented with the
rank ordering implied by their cTTO valuations in the
feedback module (see Fig. 2). The respondents were
asked to review their responses and to flag any that they
felt should be reconsidered. However, those health states
could only be flagged and not re-valued.
In the DCE tasks, respondents of both study arms
were presented with a pair of EQ-5D-5L health states: A
and B. They were asked to make a forced choice, ex-
pressing which of the two states was considered to be
the better one. Results on DCE data are reported else-
where, as this study focussed on the improvement of the
cTTO task in the EQ-VT.
Study design
The general populations’ health state valuations were col-
lected by a computer assisted personal interview (CAPI)
survey in Germany. Interviews were conducted by five aca-
demic interviewers in the following two cities and sur-
roundings located in different parts of Germany: Bielefeld
and Hanover. Individuals were recruited through a mixed
recruitment strategy, i.e. through personal contact,
newspaper advertisement and from bulletins in the univer-
sities of Bielefeld and Hanover. Interviews were conducted
in a public venue that was either a research office or a con-
ference room.
The study sample consists of a control arm (n = 100;
current EQ-VT version 1.1) and a test arm (n = 100;
modified EQ-VT version 1.1). The control arm was
asked to fill in the current version of the EQ-VT. The
test arm was asked to use the modified version 1.1 of
the EQ-VT (including the three modifications described
above). The methodological procedure of the develop-
ment of the German value set for the EQ-5D-5L will be
based on the results of the tested modifications.
The data collection was organised in a two-step ap-
proach: (1) training and pilot phase and (2) field phase.
In the first phase five academic interviewers were inten-
sively trained in a daylong training in two groups. Each
interviewer performed at least two pilot interviews for
each version of the EQ-VT (n = 4) within one week after
the interviewer training in order to test the methodo-
logical procedure (i.e. the technical implementation of
the valuation task and the interviewer role). Afterwards
the data were reviewed with the QC tool provided by
the EuroQol Group to test the interviewers’ performance
and to check for possible non-compliance to the inter-
viewer instructions (e.g. the number of moves and the
time spent explaining the cTTO task in the wheelchair
Fig. 2 The feedback module
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example) [13, 21]. Following the interviewer instruc-
tions, each respondent should be exposed to a compa-
rable survey experience (high protocol compliance).
Differences in cTTO valuations should not be related to
differences in the interview process but only to the dif-
ferences between the respondents themselves. Careful
and homogenous explanations of the wheelchair ex-
ample with regard to the duration and the iterative steps
are expected between interviewers and within an inter-
viewer. A detailed description of the QC tool can be
found elsewhere [13].
The interviewers got a written feedback for their pilot
interviews. After discussing the interviewer performance
with each interviewer, the interviewer entered the field
phase. The participants were randomly assigned to one
of the study arms by the EQ-VT. Therefore, each inter-
viewer conducted interviews in the control arm as well
as in the test arm in order to avoid an interviewer bias.
During the entire valuation study, the interviewers’
performance and the protocol compliance were evalu-
ated using the QC tool on a regular basis. The results
were regularly shared and discussed with each inter-
viewer. Each interviewer had to perform at least 35 in-
terviews to be included in the final interviewer team
which aims at a harmonised learning effect of the five
interviewers. Moreover, a written debriefing after the inter-
view of every participant provided additional information
on how the valuation interview and the performance of the
interviewer were perceived by the respondents and ensured
QC in terms of formative evaluation. The participants
received the debriefing questionnaire including the initials
of the respective interviewer and a stamped addresses
envelope. The purpose of sending the questionnaire back
by post was to avoid a bias due to the presence of the inter-
viewer while answering the questionnaire and to get an
honest appraisal of the interviewers. In addition to the
regular communication with the interviewers during
the data collection, a feedback round with all inter-
viewers was held after the field phase on how the
EQ-VT, the valuation tasks and the three modifica-
tions were perceived by the respondents and the in-
terviewers in Germany.
Data analysis
Data analysis was performed to verify the hypotheses
stated in Table 1 by gaining information on the quality
of the collected cTTO data. Descriptive analyses (propor-
tions for discrete variables, mean and standard deviation
(SD) for continuous variables) were used to examine the
following data: the background characteristics of the study
sample, the time taken to complete the valuation inter-
view and the single tasks (e.g. the wheelchair example, the
cTTO tasks and the feedback module), and the distribu-
tion of the cTTO values. Differences between the study
arms were identified via a t-test or a Mann-Whitney test
(between study arm comparisons). Differences before and
after the feedback module in the test arm were analysed
using a t-test (within subject comparisons). The harmoni-
sation level of the cTTO explanations within the study
arms were analysed using means, SD and variation coeffi-
cients of the duration and the number of moves in the
wheelchair example. The number of values at −1, −0.5, 0,
0.5 and 1 (spikes) was compared between the study arms
as well as before and after the feedback module in the test
arm using a proportion test (z-test applying Bonferroni
correction).
To evaluate the data quality in terms of consistency of
the cTTO responses, all pairs of the EQ-5D-5L health
states were identified where one health state dominates
the other one (i.e. health state A dominates health state
B when health state A is better than health state B on at
least one dimension, and not worse than health state B
on any of the remaining dimensions). An inconsistency
was defined as an observation of B (i.e. the dominated
health state) being given a higher value by a respondent
than A (i.e. the dominant health state). The level of in-
consistencies was compared using a Chi-squared test for
homogeneity between the study arms. The McNemar
test was used for analysing the effect of the feedback
module on the level of inconsistencies.
Statistical analyses were performed in STATA. The
free text answers of the debriefing questionnaire were
analysed based on a qualitative content analysis.
Results
A total of 200 interviews (n = 100 in each study arm) were
performed from 18th June – 11th August 2014. Each inter-
viewer was randomly allocated to both study arms in al-
most equal parts (the ratio of control arm to test arm
ranged from 46:54 to 53:47). Mean interview time of the
valuation interview and the country-specific questionnaire
including further background questions specific to the
German valuation study was 59.09 minutes, whereby the
test arm was about 13 min longer (control arm: 52.58 min,
test arm: 65.6 min).
Characteristics of the sample
Table 2 gives an overview of the demographics of the
study sample. Mean age of the respondents was
37.89 years. The majority of the respondents are aged
under 40 years in both study arms. Statistically significant
differences in terms of age and gender were observed be-
tween the study arms. Both sexes were included in the
study, but women were slightly overrepresented in general
(58%) and in the test arm (68%). In the control arm the
contrary can be noticed (48% female). Study participants
were mostly higher educated in both arms (83%). Study
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participants were in almost equal parts employed or non-
employed.
Self-reported health using the EQ-5D-5L showed that
about half of the sample reported no problems in any di-
mension (11111): 52% in the control arm and 49% in the
test arm. Frequencies of reported problems varied from
2% in the dimension self-care to 41.5% in the dimension
pain/discomfort (see Table 3). Small but statistically
significant differences were observed between the study
arms. However, there is no clear pattern of significantly
higher frequency of reported problems in the five di-
mensions of the descriptive system of the EQ-5D-5L in
one of the study arms. Mean self-reported health using
the EQ VAS was 87.87. Self-reported mean VAS was
lower in the control arm than in the test arm (86.74 vs.
89.00; p ≤ 0.001).
Wheelchair example
All interviewers performed interviews with both soft-
ware versions: EQ-VT version 1.1 (control arm) and
modified EQ-VT version 1.1 (test arm). Table 4 provides
an overview of the duration and the number of moves in
the wheelchair example and homogeneity of wheelchair
example within both study arms. The duration of the
wheelchair example was lower in the test arm (447 s)
compared to the control arm (477 s). The number of it-
eration steps (moves) to explain the cTTO tasks in the
wheelchair example showed a similar pattern. The variation
coefficients were lower in the test arm regarding duration,
i.e. there was a higher homogeneity of duration of the
cTTO explanation in the test arm. No statistically
significant differences were observed between the study
arms for the mean number of moves and the duration of
the wheelchair example, except for the duration of the
WTD element (138 s in the control arm vs. 100 s in the
test arm).
cTTO data
The mean duration of time spent on valuing an EQ-5D-
5L health state in the cTTO tasks was 1.85 minutes,
whereby the respondents of the test arm spent slightly
more time for each cTTO task (1.91 min in the test arm
vs. 1.71 min in the control arm; p ≤ 0.001). On average
respondents had 7.1 moves before they reached their
point of indifference in the cTTO tasks (control arm:
6.9; test arm: 7.3; p ≤ 0.05). In the test arm, completing of
the feedback module took an average of 3.37 min. In the
feedback module, 40 out of 100 respondents (40%) of the
test arm removed one or more responses. After valuing
ten health states a total of 6.7% of the responses (67 health
states) were removed by the respondents from the rank
ordering that they considered ‘wrong’. Most frequently the
values for 55555 were removed from the rank ordering.
Figure 3 gives an overview of the observed cTTO value
distribution. There are similar patterns for the cTTO
value distribution in both study arms. The majority of
the cTTO values are positive, whereas 16.8% of the
health states are valued to be WTD (control arm: 18.2%,
test arm: 15.4%; p > 0.05). The number of respondents
who provided at least one WTD response is significantly
higher in the test arm (71%) than in the control arm (62%;
p ≤ 0.001). There is no statistically significant difference in








Age, n (%) Mean (SD) 38.32 (16.34) 37.46 (15.41) 37.89 (15.88) *
18–24 13 (13%) 18 (18%) 31 (15.5%)
25–29 33 (33%) 34 (34%) 67 (33.5%)
30–39 18 (18%) 13 (13%) 31 (15.5%)
40–49 10 (10%) 7 (7%) 17 (8.5%)
50–64 17 (17%) 25 (25%) 42 (21%)
65–74 6 (6%) 1 (1%) 7 (3.5%)
> = 75 3 (3%) 2 (2%) 5 (2.5%)
Gender, n (%) Female 48 (48%) 68 (68%) 116 (58%) *
Male 52 (52%) 32 (32%) 84 (42%)
Education, n (%) Lower educationa 6 (6%) 7 (7%) 13 (6.5%) ns.
Middle educationb 11 (11%) 10 (10%) 21 (10.5%)
Higher educationc 83 (83%) 83 (83%) 166 (83%)
Employment status, n (%) Employed 53 (53%) 52 (52%) 105 (52.5%) ns.
Non-employed 47 (47%) 48 (48%) 95 (47.5%)
alower education: with or without secondary general school certificate, bmiddle education: intermediate school certificate, chigher education: entrance
qualification for universities of applied sciences, university entrance qualification, *p < 0.05
Ludwig et al. Health and Quality of Life Outcomes  (2017) 15:39 Page 7 of 13
the number of WTD values in total and per person before
and after the feedback module (p > 0.05). Differences in the
percentage of values at −1, −0.5, 0, 0.5 and 1 between the
study arms are small and not statistically significant before
and after a Bonferroni correction (p > 0.05). There is almost
no clustering of valuations at certain values on the scale
(−1, −0.5, 0, 0.5 and 1). The highest proportion of values
can be observed at 1 (control arm: 14.8%, test arm: 14%).
The proportion of health states valued at 0 is about 3% in
the control and the test arm (p > 0.05). After the feedback
module, the proportion of health states assigned at 0 is
slightly reduced (2.36%). However, the differences in










No problems 81 (81%) 87 (87%) 168 (84%) *
Slight problems 16 (16%) 9 (9%) 25 (12.5%)
Moderate problems 2 (2%) 4 (4%) 6 (3%)
Severe problems 1 (1%) 0 (0%) 1 (0.5%)
Unable 0 (0%) 0 (0%) 0 (0%)
Self-care,
n (%)
No problems 99 (99%) 97 (97%) 196 (98%) ns.
Slight problems 1 (1%) 2 (2%) 3 (1.5%)
Moderate problems 0 (0%) 1 (1%) 1 (0.5%)
Severe problems 0 (0%) 0 (0%) 0 (0%)
Unable 0 (0%) 0 (0%) 0 (0%)
Usual activities,
n (%)
No problems 79 (79%) 89 (89%) 168 (84%) *
Slight problems 20 (20%) 7 (7%) 27 (13.5%)
Moderate problems 1 (1%) 4 (4%) 5 (2.5%)
Severe problems 0 (0%) 0 (0%) 0 (0%)
Unable 0 (0%) 0 (0%) 0 (0%)
Pain/discomfort,
n (%)
No problems 55 (55%) 62 (62%) 117 (58.5%) ns.
Slight problems 33 (33%) 31 (31%) 64 (32%)
Moderate problems 11 (11%) 6 (6%) 17 (8.5%)
Severe problems 1 (1%) 1 (1%) 2 (1%)
Extreme problems 0 (0%) 0 (0%) 0 (0%)
Anxiety/depression,
n (%)
No problems 88 (88%) 74 (74%) 162 (81%) *
Slight problems 10 (10%) 21 (21%) 31 (15.5%)
Moderate problems 2 (2%) 4 (4%) 6 (3%)
Severe problems 0 (0%) 1 (1%) 1 (0.5%)
Extreme problems 0 (0%) 0 (0%) 0 (0%)
EQ VAS Mean (SD) 86.74 (10.05) 89.00 (9.19) 87.87 (9.69) *
Table 4 Duration and number moves in the wheelchair example
Control arm (n = 100) Test arm (n = 100) Total (n = 200) Sig.
Mean (SD) Variation Coeff. Mean (SD) Variation Coeff. Mean (SD) Variation Coeff.
Duration (sec.) Total time 477.65 (260.19) 0.544 447.30 (182.20) 0.407 462.47 (224.55) 0.486 ns.
BTD time 338.80 (196.62) 0.580 346.87 (147.11) 0.424 342.84 (173.25) 0.505 ns.
WTD time 138.85 (114.38) 0.824 100.43 (74.78) 0.745 119.64 (98.29) 0.822 *
Number of moves Total moves 47.81 (23.63) 0.494 43.48 (24.78) 0.570 45.64 (24.24) 0.531 ns.
BTD moves 29.90 (15.26) 0.510 28.43 (15.28) 0.538 29.17 (15.25) 0.523 ns.
WTD moves 17.91 (12.46) 0.696 15.05 (13.04) 0.866 16.48 (12.80) 0.777 ns.
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percentage of values at −1, −0.5, 0, 0.5 and 1 before and
after the feedback module are not statistically significant
before and after a Bonferroni correction (p > 0.05).
As shown in Fig. 4, the higher the severity level (i.e.
the sum of levels of all dimensions) the lower the mean
cTTO value in the control arm and the test arm (before
and after the feedback module). No statistically signifi-
cant differences were found between the study arms
(except for severity 15, p < 0.05). There is a growing vari-
ance with increasing severity, i.e. the respondents’ opin-
ions on severe health states differ more than for mild
health states. The cTTO mean score in the control arm
varies from 0.95 for the mildest health states with sever-
ity of 6 over 0.51 for health states with medium severity
level 13 to −0.36 for health states with severity 25 (i.e.
the health state 55555). The range of mean cTTO values
is marginally higher in the test arm (−0.44 for severity
25 to 0.97 for severity 6). There is a higher discrimin-
ation for severe health states in the test arm (see Fig. 4).
The feedback module had no significant effect on the
mean cTTO values (p > 0.05).
Figure 5 compares the percentage of respondents with
at least one inconsistency and the percentage of incon-
sistent cTTO responses. In the control arm, 16% of re-
spondents had at least one inconsistency in their cTTO
responses. The proportion of respondents with at least
one inconsistent response was lower in the test arm
(13%; p > 0.05) and significantly reduced after the feed-
back module (6%; p ≤ 0.001). In total, 1.9% (control arm)
and 1.4% (test arm) of all cTTO responses were incon-
sistent (p > 0.05). The level of inconsistencies was signifi-
cantly reduced by 50% after the feedback module (before
the feedback module: 1.4%, after the feedback module:
0.7%; p = 0.01). Moreover, the proportion of respondents
who did not value the health state 55555 the lowest is
6% in both study arms. After the feedback module,
1.08% of the respondents still did not value health state
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Fig. 4 Mean cTTO value by severity
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Debriefing of the respondents and the interviewers
An additional written debriefing of the respondents pro-
vided information on the performance of the five inter-
viewers perceived by the respondents (n = 96; 48%
response rate). According to the results of the debrief-
ing, 92.7% of the interviewers fully explained the back-
ground and the aim of this valuation study. In total,
64.58% of the respondents strongly agreed that the
duration of the interview was appropriate. However, the
content analysis of the open questions showed that
many respondents of the test arm evaluated the ranking
task of the ten health states to last too long and to be
too difficult to decide on at the beginning of the inter-
view: “I was overburdened when I was ask to rank 10
health states and the ‘death’ at the beginning of the inter-
view because the health states looked so similar. It was
really difficult to decide on the ranking based on my pref-
erences as I never thought about those health states be-
fore”. The majority of the respondents described the
cTTO tasks to be clear and comprehensible (strongly
agree: 50%, rather agree: 43.75%). The respondents of
the test arm mentioned in the comment box that the
possibility to park severe health states facilitates the
valuation of these health states at the end of the cTTO
tasks. Moreover, the majority of the respondents of the
test arm liked the possibility to review their cTTO re-
sponses in the feedback module and to correct for
wrong answers given (strongly agree: 60%, rather agree:
26%). “During the [cTTO] tasks I could not remember all
of my previous answers. It was good that I could see the
ranking based on my answers at the end of the section
and that I could make corrections”.
Besides the regular communication during the whole
study, a feedback group discussion was held with all
interviewers. The interviewers themselves enjoyed per-
forming the interviews and got positive feedback during
and after the interviews. Both software versions used,
the EQ-VT version 1.1 and the modified EQ-VT version
1.1, in combination with the interviewer instructions
and the feedback from the routine QC checks were
regarded as feasible and comprehensible. Evaluating the
different software versions, the interviewers criticised
the high cognitive burden of the ranking task at the early
stage of the interviews. Many respondents were over-
strained and needed a lot of support to fulfil the ranking
task. Besides the increased complexity and duration of
the whole valuation interview, the interviewers felt that
the ranking task did not facilitate the following cTTO
tasks and judged this modification as “unnecessary pro-
longation of the interview”. Regarding the modification
of the BTD/WTD split, the interviewers reported that
(the split of ) the wheelchair example in the test arm was
regarded as being more feasible. It was easier for them
to firstly explain the BTD task and later on the WTD
task as there was no overburdening of the respondents
at the wheelchair example. Explaining conventional
TTO for BTD and LT-TTO for WTD simultaneously
was regarded as an interruption of thinking in the
current EQ-VT version 1.1 (used in the control arm of
this study). “Moreover, many respondents in the test arm
liked to temporally park severe health states, to continue
with mild health states [in the BTD format] and to value
the severe health states at the end again [in the WTD
format]. These decisions were judged as being easier”.
The feedback module was regarded as a useful modifica-
tion, especially for the respondents who would like to
correct their answers as this is not possible in the
current EQ-VT 1.1. However, other respondents must
be strongly encouraged by the interviewers to review the
ten health states again.
Discussion
This paper presents the results of the collected cTTO
data of an exploratory German EQ-5D-5L valuation
study. The improved valuation protocol combined with
an intensive interviewer training and a close data moni-
toring showed a high feasibility and acceptability by the
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Fig. 5 Inconsistencies of cTTO values
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interviewers in Germany. Cognitive debriefing exercises
provided additional information on how the EQ-VT ver-
sion 1.1, the valuation tasks and the three modifications
were perceived by the respondents and the interviewers.
The different steps of strict QC contributed to a high
data quality in both study arms. Compared to the first
wave of EQ-5D-5L valuation studies using the EQ-VT
version 1.0 [9, 11] there were fewer data issues in both
study arms:
 the presented data showed few inconsistencies in
total as well as those concerning the worst health
state 55555 (at least 20% in the first valuation
studies versus 6% in this study),
 a few “spikes” at 0.5 and (−)1 (in the first valuation
studies spikes at −1, −0.5, 0, 0.5 and 1),
 a small gap between the mildest health state and full
health (e.g. 0.90-0.92 for severity 6 in the valuation
study in the Netherlands versus 0.96 in this study),
 moreWTD responses (16.8% in this study) [9–11, 22].
As this clear improvement of data quality can be iden-
tified in both study arms, it might be related to the three
modifications which were added to the protocol and led
to the EQ-VT version 1.1 (i.e. routine QC checks, adding
three practise health states and a prompt after each an-
swer). However, the gap between −0.5 and 0 still exists.
This might be partly related to the iterative routing of
the EQ-VT: each time the respondent moves to the
WTD element, the second iteration step is 0.5 and the next
steps are half-year steps in contrast to annual steps in the
BTD element, i.e. trading between 5 and 0 years of the
lead time requires more iterative steps compared to the
BTD element. Alternative routing procedures of the WTD
element which is adapted to the BTD element should be
an objective of future research around the EQ-VT.
It has to be restrictively mentioned that the modifica-
tion of the three add-ons was tested simultaneously in
this study. Therefore the results of other experimental
studies of the EQ-VT research methodology programme
testing a single modification each were additionally in-
cluded in the final decision of the methodology for the
German EQ-5D-5L valuation study. In those studies
each experimental arm applied only one modification to
the EQ-VT [9].
Firstly, it was hypothesised that the introduction of the
ranking task prior to the cTTO valuations will reduce
the inconsistencies and improves the overall data quality.
The test arm resulted in a higher data quality in terms
of fewer inconsistencies. However, the hypothesis cannot
be verified based on the quantitative data analysis of this
study as the EQ-VT version of the test arm also included
two further modifications. The debriefing of the respon-
dents and the interviewers showed that the ranking task
itself implied a high cognitive burden to the respondents
and increased the complexity as well as the duration of
the interview (about 10 min as recorded in the EQ-VT).
On average, the ranking task prolonged the interviews
about 8 min in other countries and increased the com-
plexity of the studies [9]. The EQ-VT methodology re-
search programme of the EuroQol Group came to the
result that the ranking task with sorting reduced the face
validity of the data. The feasibility and acceptability to
respondents and interviewers are low [9, 21]. Overall,
this led to the decision not to implement the ranking
task in the main valuation study in Germany.
Secondly, separating the BTD and WTD TTO tasks
tested the hypothesis that this will reduce the inconsist-
encies of the valuations and improves the overall data
quality. The test arm resulted in a higher data quality in
terms of higher values for mild heath states (0.97 versus
0.95 for severity level 6) and fewer inconsistencies (1.4%
versus 1.9%). The reduction of spikes compared to the
first wave of valuation studies can be noticed in both
study arms. The discriminative capability for severe
health states is higher in the test arm in comparison to
the control arm. The total amount of WTD values in
the test arm was increased (15.4%) compared to the first
wave of valuation studies but it was slightly lower than
in the control arm (18.2%). However, the tested hypoth-
esis also cannot be verified solely on the quantitative
data analysis of this study as the test arm applied a soft-
ware including further modifications. The BTD/WTD
split study of the EQ-VT methodology research
programme in the Netherlands found that it promotes
consistency in the data [9, 22]. As the results of an
equivalent study in Hong Kong did not confirm this, no
clear recommendation could be derived from the EQ-
VT methodology research programme. However, the
debriefing of the respondents in this study showed that
they were in favour of temporally parking severe health
states which made it easier for them to decide on these
health states after valuing all BTD health states. More-
over, the interviewers reported that it was easier for
them to split the explanation of the BTD element and the
WTD element as there was no overburdening of the re-
spondents during the wheelchair example. They felt that
explaining both cTTO tasks at the same time, i.e. the con-
ventional TTO for BTD and the LT-TTO for WTD, is an
interruption of thinking in the current EQ-VT version 1.1.
In accordance with the debriefing results of the inter-
viewers, the data analysis confirmed a significantly lower
and more homogenous duration of the WTD element in
the wheelchair example while keeping an adequate level of
the protocol compliance. In summary, based on the re-
sults of this exploratory study in Germany and the study
in the Netherlands it was decided to implement the BTD/
WTD split in the main valuation study in Germany.
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Thirdly, it was tested whether the addition of the feed-
back module, i.e. presenting respondents with the rank
ordering implied by their cTTO valuations, will reduce
inconsistencies as they will identify and flag problematic
valuations for removal from the data. The feedback
module increases interview length by 3.37 min. The
feedback module had no significant effect on mean
cTTO values, but significantly reduced the level of in-
consistencies from 1.4% (test arm before feedback mod-
ule) to 0.7%. So, the stated hypothesis can be verified
based on the presented data. Other studies, like in Spain
and the Netherlands, also confirm that this modification
statistically increased the proportion of consistent re-
spondents [9, 22]. Moreover, respondents of this study
reported that they liked to remove problematic valua-
tions after having seen all ten health states. So, the feed-
back module will be implemented in the main EQ-5D-
5L valuation study in Germany.
Besides the above stated limitation of testing three
modifications at the same time, there are further limita-
tions to be mentioned. Respondents were partly recruited
using convenience sampling within the university context.
Compared to the general population in Germany, young
and highly educated persons were therefore overrepre-
sented in this study [23]. Thus it would be unjustified to
suggest that the data are representative of the whole
German population. The feasibility and acceptability of
the improved EQ-5D-5L valuation protocol need to be
further investigated in future valuation studies, especially
in older and lower educated people. However, for the pur-
pose of this experimental study a strict representativeness
of the German general population was not required.
Moreover, even though the participants were randomly
assigned to one of the study arms by the EQ-VT, there are
differences between the study arms regarding socio-
demographics and health status which might account
for some of the observed variation in respondents’
values. However, the interviewers conducted inter-
views in the control arm as well as in the test arm to
avoid further differences between the study arms due
to an interviewer bias.
According to the EQ-5D-5L valuation protocol 1.1, the
LT-TTO used in this study applied a twenty year time
frame (i.e. ten years of lead time followed by ten years in
impaired health), which implied that it was possible to
trade-off a maximum of ten years of lead time (mini-
mum value of −1). However, there were no information
collected whether the value −1 or even a lower value
was the respondents’ preference. Therefore, it cannot be
excluded that respondents would have trade-off even
more life years in full health than the maximum possible
(longer lead time), in which case their value would be
lower than −1 [8, 24]. Methods have been recently devel-
oped to model value sets taking into account those
cTTO data bounded at −1 (censoring) [8, 10, 24]. How-
ever, additional (trade-off ) questions could be asked of
those respondents who traded the whole lead time as
object of research in future EQ-5D-5L valuation studies.
The influence of time discounting on cTTO values
was not regarded in this experimental study as the focus
was on testing the EQ-VT 1.1 and the further three
modifications. Thereby, a possibly resulting downward
bias cannot be excluded [15, 25]. More exploratory re-
search is required to develop ways of controlling for
time preferences in the estimation of cTTO tariffs.
Thereby different discount rate elicitation procedures
should be developed and their feasibility as well as their
validity in general population samples should be ex-
plored [15, 16, 25].
Conclusions
This exploratory study showed the feasibility and accept-
ability of the improved EQ-5D-5L valuation protocol in
Germany and resulted in higher data quality in both
study arms compared to the first wave of EQ-5D-5L
valuation studies. It can be concluded that the modifica-
tions of the international EQ-5D-5L valuation protocol
from EQ-VT version 1.0 to EQ-VT version 1.1 had a
positive impact on the data quality and provided evi-
dence for continuing with the cTTO-based valuation
protocol in future valuation studies.
Based on the results of this study and other studies of
the EQ-VT research methodology programme [9], it was
decided to implement two modifications in the main EQ-
5D-5L valuation study in Germany: splitting the TTO
tasks for the health states BTD and WTD as well as the
inclusion of the feedback module. The BTD / WTD split
version showed a higher feasibility and acceptance by the
participants as well as the interviewers and the feedback
module resulted in the lowering of inconsistencies.
This study assured the feasibility and acceptability of
the improved EQ-5D-5L valuation protocol in Germany
and builds an empirical basis for the coming valuation
study in Germany. The German value set for the EQ-
5D-5L will be expected in 2017. The final German value
set might facilitate the use of the EQ-5D-5L in a range
of applications for health care policy and clinical assess-
ment in Germany and other German-speaking countries.
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